BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23858028)

  • 1. CCL19 and CCL28 augment mucosal and systemic immune responses to HIV-1 gp140 by mobilizing responsive immunocytes into secondary lymph nodes and mucosal tissue.
    Hu K; Luo S; Tong L; Huang X; Jin W; Huang W; Du T; Yan Y; He S; Griffin GE; Shattock RJ; Hu Q
    J Immunol; 2013 Aug; 191(4):1935-47. PubMed ID: 23858028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge.
    Yan Y; Hu K; Deng X; Guan X; Luo S; Tong L; Du T; Fu M; Zhang M; Liu Y; Hu Q
    J Immunol; 2015 Jul; 195(1):329-38. PubMed ID: 25994965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL19 and CCL28 Assist Herpes Simplex Virus 2 Glycoprotein D To Induce Protective Systemic Immunity against Genital Viral Challenge.
    Yan Y; Hu K; Fu M; Deng X; Luo S; Tong L; Guan X; He S; Li C; Jin W; Du T; Zheng Z; Zhang M; Liu Y; Hu Q
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33910988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands.
    Eo SK; Lee S; Kumaraguru U; Rouse BT
    Vaccine; 2001 Sep; 19(32):4685-93. PubMed ID: 11535317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimeric HIV-1 gp140 fused with APRIL, BAFF, and CD40L on the mucosal gp140-specific antibody responses in mice.
    Liu J; Clayton K; Gao W; Li Y; Zealey C; Budylowski P; Schwartz J; Yue FY; Bie Y; Rini J; Ostrowski M
    Vaccine; 2020 Feb; 38(9):2149-2159. PubMed ID: 32014267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine.
    Gary EN; Kathuria N; Makurumidze G; Curatola A; Ramamurthi A; Bernui ME; Myles D; Yan J; Pankhong P; Muthumani K; Haddad E; Humeau L; Weiner DB; Kutzler MA
    Vaccine; 2020 Mar; 38(11):2626-2635. PubMed ID: 32057572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of ccl19 gene enhances anti-caries DNA vaccine pCIA-P immunogenicity in mice by increasing dendritic cell migration to secondary lymphoid tissues.
    Yan YH; Qi SC; Su LK; Xu QA; Fan MW
    Acta Pharmacol Sin; 2013 Mar; 34(3):432-40. PubMed ID: 23334235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
    Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
    Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
    Staats HF; Nichols WG; Palker TJ
    J Immunol; 1996 Jul; 157(1):462-72. PubMed ID: 8683152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non-Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae.
    Aldon Y; Kratochvil S; Shattock RJ; McKay PF
    J Immunol; 2020 Feb; 204(4):903-913. PubMed ID: 31915263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
    Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
    J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL17 combined with CCL19 as a nasal adjuvant enhances the immunogenicity of an anti-caries DNA vaccine in rodents.
    Yan YH; Yu F; Zeng C; Cao LH; Zhang Z; Xu QA
    Acta Pharmacol Sin; 2016 Sep; 37(9):1229-36. PubMed ID: 27546005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates.
    Lehner T; Bergmeier LA; Tao L; Panagiotidi C; Klavinskis LS; Hussain L; Ward RG; Meyers N; Adams SE; Gearing AJ
    J Immunol; 1994 Aug; 153(4):1858-68. PubMed ID: 7519218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective expansion of HIV-1 envelope glycoprotein-specific B cell subsets recognizing distinct structural elements following immunization.
    Dosenovic P; Chakrabarti B; Soldemo M; Douagi I; Forsell MN; Li Y; Phogat A; Paulie S; Hoxie J; Wyatt RT; Karlsson Hedestam GB
    J Immunol; 2009 Sep; 183(5):3373-82. PubMed ID: 19696434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
    Kaneko H; Bednarek I; Wierzbicki A; Kiszka I; Dmochowski M; Wasik TJ; Kaneko Y; Kozbor D
    Virology; 2000 Feb; 267(1):8-16. PubMed ID: 10648178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
    Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
    J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.
    Buonaguro L; Devito C; Tornesello ML; Schröder U; Wahren B; Hinkula J; Buonaguro FM
    Vaccine; 2007 Aug; 25(32):5968-77. PubMed ID: 17629365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies.
    Bower JF; Li Y; Wyatt R; Ross TM
    Vaccine; 2006 Jun; 24(26):5442-51. PubMed ID: 16621193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccine.
    Hamajima K; Hoshino Y; Xin KQ; Hayashi F; Tadokoro K; Okuda K
    Clin Immunol; 2002 Jan; 102(1):12-8. PubMed ID: 11781062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination.
    Song JH; Kim JI; Kwon HJ; Shim DH; Parajuli N; Cuburu N; Czerkinsky C; Kweon MN
    J Immunol; 2009 Jun; 182(11):6851-60. PubMed ID: 19454681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.